Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,263 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice].
Benchaouir R, Meregalli M, Farini A, D'Antona G, Belicchi M, Goyenvalle A, Battistelli M, Bresolin N, Bottinelli R, Garcia L, Torrente Y. Benchaouir R, et al. Among authors: garcia l. Med Sci (Paris). 2008 Jan;24(1):99-101. doi: 10.1051/medsci/200824199. Med Sci (Paris). 2008. PMID: 18198122 Free article. French. No abstract available.
Therapeutic exon 'switching' for dysferlinopathies?
Lévy N, Wein N, Barthelemy F, Mouly V, Garcia L, Krahn M, Bartoli M. Lévy N, et al. Among authors: garcia l. Eur J Hum Genet. 2010 Sep;18(9):969-70; author reply 971. doi: 10.1038/ejhg.2010.73. Epub 2010 May 26. Eur J Hum Genet. 2010. PMID: 20512160 Free PMC article. No abstract available.
Muscle function recovery in golden retriever muscular dystrophy after AAV1-U7 exon skipping.
Vulin A, Barthélémy I, Goyenvalle A, Thibaud JL, Beley C, Griffith G, Benchaouir R, le Hir M, Unterfinger Y, Lorain S, Dreyfus P, Voit T, Carlier P, Blot S, Garcia L. Vulin A, et al. Among authors: garcia l. Mol Ther. 2012 Nov;20(11):2120-33. doi: 10.1038/mt.2012.181. Epub 2012 Sep 11. Mol Ther. 2012. PMID: 22968479 Free PMC article.
Exon skipping as a therapeutic strategy applied to an RYR1 mutation with pseudo-exon inclusion causing a severe core myopathy.
Rendu J, Brocard J, Denarier E, Monnier N, Piétri-Rouxel F, Beley C, Roux-Buisson N, Gilbert-Dussardier B, Perez MJ, Romero N, Garcia L, Lunardi J, Fauré J, Fourest-Lieuvin A, Marty I. Rendu J, et al. Among authors: garcia l. Hum Gene Ther. 2013 Jul;24(7):702-13. doi: 10.1089/hum.2013.052. Hum Gene Ther. 2013. PMID: 23805838 Free PMC article.
3,263 results